Fortrea and Medidata Join Forces to Improve Diversity in Clinical Trials

Why It Matters:

This collaboration addresses the longstanding issue of diversity in clinical trials, aiming to improve representation and ensure that enrollment targets reflect the populations affected by various diseases or conditions.

The Details:

• Fortrea and Medidata have formed a strategic partnership to leverage Medidata's AI Intelligent Trials technology.

• The partnership builds upon Fortrea's existing use of Medidata's Rave EDC solution for managing clinical trial sites and data.

• The integration of Medidata's AI technology allows Fortrea to enhance its services for biopharmaceutical companies, medical device firms, and diagnostic companies.

• The AI Intelligent Trials technology focuses on study feasibility and provides diverse data to aid in meeting enrollment targets.

Conclusion:

Through this partnership, Fortrea and Medidata aim to accelerate study timelines and make the benefits of clinical therapies more accessible to a diverse range of individuals.